the need for novel therapeutic agents in myeloproliferative neoplasms
Published 2 years ago • 114 plays • Length 1:33Download video MP4
Download video MP3
Similar videos
-
2:22
the need for novel agents to treat patients with mcl who have relapsed after targeted therapy
-
3:24
novel agents for the management of r/r myeloma
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
3:02
novel treatments and ongoing clinical trials for wm: targeted agents and immunotherapies
-
3:54
an insight into how novel agents are influencing survival outcomes in patients with mf
-
1:04
exciting updates in mf: novel targets and agents
-
5:19
mpn hero mayra andújar: a guiding light for people with mpns
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
4:20
therapy-related all: etiology, prognosis, and treatment
-
2:16
the unmet needs of patients who have visual impairment as a consequence of scd
-
3:51
novel agents in mzl: btkis, pi3k inhibitors, and immunotherapeutics
-
2:43
gemtuzumab ozogamicin in frontline aml therapy
-
1:14
promising novel agents in aml: menin inhibitors
-
1:15
bringing novel agents to the frontline setting in myeloma
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
1:50
the value of moving novel agents into the frontline setting in all
-
3:01
novel promising agents and clinical trials in amyloidosis
-
1:53
how novel agents may eliminate the need for transplant in all
-
1:49
managing treatment toxicities when developing novel agents for mpns
-
1:31
novel treatment agents and how they're changing the mpn field
-
2:06
how the mpn field has evolved over the years: novel agents, trials, and more